Processa Pharma Stock (NASDAQ: PCSA) stock price, news, charts, stock research, profile.
Open | $2.340 |
Close | $2.365 |
Volume / Avg. | 165.956K / 1.534M |
Day Range | 2.270 - 2.460 |
52 Wk Range | 2.020 - 18.000 |
Market Cap | $4.081M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 6.32% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Processa Pharma (NASDAQ: PCSA) through any online brokerage.
Other companies in Processa Pharma’s space includes: Cingulate (NASDAQ:CING), Pulmatrix (NASDAQ:PULM), Biofrontera (NASDAQ:BFRI), Titan Pharma (NASDAQ:TTNP) and 60 Degrees (NASDAQ:SXTP).
The latest price target for Processa Pharma (NASDAQ: PCSA) was reported by Benchmark on Wednesday, March 6, 2024. The analyst firm set a price target for 4.00 expecting PCSA to rise to within 12 months (a possible 67.36% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Processa Pharma (NASDAQ: PCSA) is $2.39 last updated Today at March 28, 2024 at 8:57 AM EDT.
There are no upcoming dividends for Processa Pharma.
Processa Pharma’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Processa Pharma.
Processa Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.